Literature DB >> 29238514

Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus.

Baris Saglam1, Sezer Uysal2, Sadik Sozdinler3, Omer Erbil Dogan3, Banu Onvural1.   

Abstract

BACKGROUND: The oral glucose tolerance test (OGTT) is the current established method performed worldwide to diagnose gestational diabetes mellitus (GDM). The purpose of this study was to assess the utility of the use of long- and short-term markers of glycemic status.
METHODS: The study group was composed of 80 pregnant women, 40 with GDM and 40 with normal glucose tolerance. GDM was diagnosed with the American Diabetes Association criteria. Glycemic markers were measured in the OGTT blood samples of women at 24-28 weeks of gestation.
RESULTS: HbA1c was significantly higher in the GDM group when compared with the controls, whereas 1,5-anhydroglucitol (1,5-AG) levels were significantly lower. There was not a significant difference between the groups for glycated albumin. Whereas HbA1c levels were correlated with fasting and 1 h glucose and negatively correlated with mean corpuscular volume, 1,5-AG was only negatively correlated with the first hour glucose. No difference was found for the diagnostic performances of HbA1c and 1,5-AG (receiver operating characteristic of the area under the concentration curve values were 0.756 and 0.722, respectively).
CONCLUSION: HbA1c and 1,5-AG alone does not have sufficient diagnostic accuracy to diagnose GDM. 1,5-AG values were correlated with post-load glucose values in pregnant women so will improve the GDM management and be useful to predict complications.

Entities:  

Keywords:  1,5-anhydroglucitol; HbA1c; gestational diabetes mellitus; glycated albumin

Year:  2017        PMID: 29238514      PMCID: PMC5721970          DOI: 10.1177/2042018817742580

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  30 in total

1.  Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy.

Authors:  Yuji Hiramatsu; Ikki Shimizu; Yasue Omori; Masao Nakabayashi
Journal:  Endocr J       Date:  2011-12-14       Impact factor: 2.349

2.  Glycated albumin level during late pregnancy as a predictive factor for neonatal outcomes of women with diabetes.

Authors:  Daisuke Sugawara; Hiroaki Sato; Ko Ichihashi; Kohei Nagai; Atsuko Kawano
Journal:  J Matern Fetal Neonatal Med       Date:  2017-06-09

3.  The predictive value of serum 1,5-anhydro-D-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance.

Authors:  W H Tam; M S Rogers; T K Lau; M Arumanayagam
Journal:  BJOG       Date:  2001-07       Impact factor: 6.531

4.  Analytical evaluation of the Diazyme glycated serum protein assay on the siemens ADVIA 1800: comparison of results against HbA1c for diagnosis and management of diabetes.

Authors:  Karina Rodriguez-Capote; Kayla Tovell; Deborah Holmes; Janice Dayton; Trefor N Higgins
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

5.  Impact of Mean Cell Hemoglobin on Hb A1c-Defined Glycemia Status.

Authors:  Santiago Rodriguez-Segade; Javier Rodriguez Garcia; José M García-López; Francisco Gude; Felipe F Casanueva; Santiago Rs-Alonso; Félix Camiña
Journal:  Clin Chem       Date:  2016-09-27       Impact factor: 8.327

6.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

7.  Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.

Authors:  Thyparambil Aravindakshan Pramodkumar; Ramamoorthy Jayashri; Kuppan Gokulakrishnan; Kaliyaperumal Velmurugan; Rajendra Pradeepa; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

8.  The diagnostic value of glycated albumin in gestational diabetes mellitus.

Authors:  Jieping Zhu; Yu Chen; Changbin Li; Minfang Tao; Yincheng Teng
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

9.  Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.

Authors:  Cong Ma; Junqin Sheng; Zhiwen Liu; Minghao Guo
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

10.  Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus.

Authors:  Hua-Ping Li; Feng-Huan Wang; Min-Fang Tao; Ya-Juan Huang; Wei-Ping Jia
Journal:  J Diabetes Investig       Date:  2015-07-14       Impact factor: 4.232

View more
  3 in total

1.  Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial.

Authors:  Yuan Yu; Qun Yan; Huizhi Li; Hongmei Li; Lin Wang; Hua Wang; Yiyun Zhang; Lei Xu; Zhaosheng Tang; Xinfeng Yan; Yinghua Chen; Huili He; Jie Chen; Bo Feng
Journal:  J Diabetes Investig       Date:  2019-03-19       Impact factor: 4.232

2.  Maternal glycemic parameters and adverse pregnancy outcomes among high-risk pregnant women.

Authors:  Yanwei Zheng; Yun Shen; Susu Jiang; Xiaojing Ma; Jiangshan Hu; Changbin Li; Yajuan Huang; Yincheng Teng; Yuqian Bao; Jian Zhou; Gang Hu; Minfang Tao
Journal:  BMJ Open Diabetes Res Care       Date:  2019-11-13

3.  Glycated albumin in pregnancy: reference intervals establishment and its predictive value in adverse pregnancy outcomes.

Authors:  Ying Dong; Yanhong Zhai; Jing Wang; Yi Chen; Xin Xie; Chunhong Zhang; Jingrui Liu; Yifan Lu; Guodong Tang; Lican Han; Lin Li; Zheng Cao
Journal:  BMC Pregnancy Childbirth       Date:  2020-01-03       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.